企業プロフィール
Merck 株価・ニュース・カタリスト
- ティッカー:
- MRK
- 取引所:
- NYSE
- セクター:
- Oncology, Immunotherapy, Vaccines
- 所在地:
- United States
株価パフォーマンス
135.97 USD (+0.10%)
終値
最終更新: 2026年8月17日
286B USD
時価総額
株価変動の要因
As of Aug 17, 2026, MRK was little changed and closed at $135.97. No new same-company headline was identified in the current news window.
企業概要
事業概要
Merck is a diversified pharmaceutical company with major exposure to oncology, vaccines, infectious disease, and animal health. The company’s market story still revolves around Keytruda, pipeline replacement, and the durability of its broader portfolio.
所在地とセクター分類
Headquartered in the United States and listed on NYSE, Merck has a global pharmaceutical footprint with strong international reach. It sits in large-cap biopharma and not in a narrow biotech niche.
ビジネスモデルの特徴
Merck generates revenue from a mix of blockbuster products, vaccines, and pipeline assets. Investors watch oncology growth, patent lifecycle pressure, vaccine demand, and whether the next wave of products can offset concentration risk.
バイオ業界での位置付け
Merck is a mature large-cap pharma name with meaningful biotech-like catalyst sensitivity around oncology and vaccine updates. It is less volatile than clinical-stage companies, but major pipeline or label events can still move sentiment.
今後のカタリスト
- Merck’s next three months are likely to focus on Winrevair uptake, oncology execution, and any pipeline readout that helps replace the market’s dependence on Keytruda. That readout matters because it decides whether the asset is ready for a larger and more expensive development step. If the data come in cleanly, the market tends to give the broader platform behind the program more credit.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。